CTA
CBAY

Carillon Tower Advisers’s Cymabay Therapeutics CBAY Stock Holding History

Carillon Tower Advisers’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,061,772
Closed -$10.6M – 489
2019
Q3 		$10.6M Hold
2,061,772
– – 0.07% 325
2019
Q2 		$14.8M Hold
2,061,772
– – 0.1% 285
2019
Q1 		$27.4M Hold
2,061,772
– – 0.19% 195
2018
Q4 		$16.2M Hold
2,061,772
– – 0.14% 240
2018
Q3 		$22.8M Buy
2,061,772
+614,502
+42% +$7.63M 0.16% 213
2018
Q2 		$19.4M Buy
+1,447,270
New +$18.1M 0.15% 219

Other funds holding CBAY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return